Results of the combined analysis suggest that serum level of LAMC2 and CA19-9 were higher in the PDAC patients than that of non-tumor patients/heathy donor from USA, German and Japan cohorts (p<0.05, Figure 6G–6I, Supplementary Table 3). The gene discussed is LAMC2; the disease is neoplasm.